PMC:7311890 / 11244-11522
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T95","span":{"begin":153,"end":157},"obj":"Body_part"}],"attributes":[{"id":"A95","pred":"fma_id","subj":"T95","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Our observations were aligned with previous findings on laboratory-confirmed COVID-19 cases in Wuhan for which particularly drastic reductions in CD4+ T cell counts indicative of dysregulated immune response were noted, especially in severe COVID-19 patients (Qin et al., 2020)."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T71","span":{"begin":77,"end":85},"obj":"Disease"},{"id":"T72","span":{"begin":241,"end":249},"obj":"Disease"}],"attributes":[{"id":"A71","pred":"mondo_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A72","pred":"mondo_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Our observations were aligned with previous findings on laboratory-confirmed COVID-19 cases in Wuhan for which particularly drastic reductions in CD4+ T cell counts indicative of dysregulated immune response were noted, especially in severe COVID-19 patients (Qin et al., 2020)."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T88","span":{"begin":146,"end":149},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T89","span":{"begin":151,"end":157},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"Our observations were aligned with previous findings on laboratory-confirmed COVID-19 cases in Wuhan for which particularly drastic reductions in CD4+ T cell counts indicative of dysregulated immune response were noted, especially in severe COVID-19 patients (Qin et al., 2020)."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"394","span":{"begin":146,"end":149},"obj":"Gene"},{"id":"400","span":{"begin":250,"end":258},"obj":"Species"},{"id":"405","span":{"begin":77,"end":85},"obj":"Disease"},{"id":"406","span":{"begin":241,"end":249},"obj":"Disease"}],"attributes":[{"id":"A394","pred":"tao:has_database_id","subj":"394","obj":"Gene:920"},{"id":"A400","pred":"tao:has_database_id","subj":"400","obj":"Tax:9606"},{"id":"A405","pred":"tao:has_database_id","subj":"405","obj":"MESH:C000657245"},{"id":"A406","pred":"tao:has_database_id","subj":"406","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Our observations were aligned with previous findings on laboratory-confirmed COVID-19 cases in Wuhan for which particularly drastic reductions in CD4+ T cell counts indicative of dysregulated immune response were noted, especially in severe COVID-19 patients (Qin et al., 2020)."}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T26","span":{"begin":192,"end":207},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"Our observations were aligned with previous findings on laboratory-confirmed COVID-19 cases in Wuhan for which particularly drastic reductions in CD4+ T cell counts indicative of dysregulated immune response were noted, especially in severe COVID-19 patients (Qin et al., 2020)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T68","span":{"begin":0,"end":278},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Our observations were aligned with previous findings on laboratory-confirmed COVID-19 cases in Wuhan for which particularly drastic reductions in CD4+ T cell counts indicative of dysregulated immune response were noted, especially in severe COVID-19 patients (Qin et al., 2020)."}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T275","span":{"begin":77,"end":85},"obj":"SP_7"},{"id":"T276","span":{"begin":146,"end":149},"obj":"PR:000001004"},{"id":"T277","span":{"begin":151,"end":157},"obj":"CL:0000084"},{"id":"T278","span":{"begin":179,"end":191},"obj":"GO:0065007"},{"id":"T279","span":{"begin":192,"end":198},"obj":"UBERON:0002405;GO:0006955"},{"id":"T280","span":{"begin":199,"end":207},"obj":"GO:0006955"},{"id":"T281","span":{"begin":241,"end":249},"obj":"SP_7"},{"id":"T86499","span":{"begin":92,"end":97},"obj":"NCBITaxon:10239"},{"id":"T73491","span":{"begin":199,"end":208},"obj":"CHEBI:59132;CHEBI:59132"}],"text":"Our observations were aligned with previous findings on laboratory-confirmed COVID-19 cases in Wuhan for which particularly drastic reductions in CD4+ T cell counts indicative of dysregulated immune response were noted, especially in severe COVID-19 patients (Qin et al., 2020)."}